Morgan Stanley’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $132M | Sell |
1,233,498
-98,044
| -7% | -$11.9M | 0.01% | 1337 |
|
|
2026
Q1 | $218M | Sell |
1,331,542
-300,364
| -18% | -$46.2M | 0.01% | 905 |
|
|
2025
Q4 | $284M | Buy |
1,631,906
+668,275
| +69% | +$122M | 0.02% | 760 |
|
|
2025
Q3 | $139M | Sell |
963,631
-80,160
| -8% | -$9.82M | 0.01% | 1153 |
|
|
2025
Q2 | $105M | Sell |
1,043,791
-15,865
| -1% | -$1.21M | 0.01% | 1282 |
|
|
2025
Q1 | $80.8M | Sell |
1,059,656
-291,709
| -22% | -$22.3M | 0.01% | 1406 |
|
|
2024
Q4 | $93.3M | Buy |
1,351,365
+30,374
| +2% | +$2.19M | 0.01% | 1304 |
|
|
2024
Q3 | $96.4M | Buy |
1,320,991
+498,187
| +61% | +$36.8M | 0.01% | 1268 |
|
|
2024
Q2 | $55.1M | Sell |
822,804
-116,799
| -12% | -$4.53M | ﹤0.01% | 1670 |
|
|
2024
Q1 | $25.5M | Sell |
939,603
-595,144
| -39% | -$16.7M | ﹤0.01% | 2425 |
|
|
2023
Q4 | $47.6M | Buy |
1,534,747
+856,021
| +126% | +$22.2M | ﹤0.01% | 1778 |
|
|
2023
Q3 | $17.1M | Buy |
678,726
+253,242
| +60% | +$5.79M | ﹤0.01% | 2628 |
|
|
2023
Q2 | $8.98M | Sell |
425,484
-361,997
| -46% | -$6.87M | ﹤0.01% | 3264 |
|
|
2023
Q1 | $13.4M | Sell |
787,481
-189,459
| -19% | -$3.68M | ﹤0.01% | 2866 |
|
|
2022
Q4 | $19.5M | Buy |
976,940
+312,505
| +47% | +$6.04M | ﹤0.01% | 2368 |
|
|
2022
Q3 | $14.3M | Sell |
664,435
-172,483
| -21% | -$4.14M | ﹤0.01% | 2575 |
|
|
2022
Q2 | $16.5M | Sell |
836,918
-9,848
| -1% | -$206K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $19.9M | Buy |
846,766
+290,597
| +52% | +$6.75M | ﹤0.01% | 2118 |
|
|
2021
Q4 | $15.2M | Sell |
556,169
-337,803
| -38% | -$9.66M | ﹤0.01% | 2472 |
|
|
2021
Q3 | $24.6M | Buy |
893,972
+64,221
| +8% | +$1.68M | ﹤0.01% | 1872 |
|
|
2021
Q2 | $23.6M | Buy |
829,751
+267,684
| +48% | +$7.94M | ﹤0.01% | 1976 |
|
|
2021
Q1 | $19.1M | Sell |
562,067
-41,031
| -7% | -$1.57M | ﹤0.01% | 1961 |
|
|
2020
Q4 | $20.1M | Buy |
603,098
+171,121
| +40% | +$6.25M | ﹤0.01% | 1802 |
|
|
2020
Q3 | $13.9M | Sell |
431,977
-84,410
| -16% | -$2.43M | ﹤0.01% | 1754 |
|
|
2020
Q2 | $14.2M | Sell |
516,387
-230
| -0% | -$5.45K | ﹤0.01% | 1670 |
|
|
2020
Q1 | $8.28M | Sell |
516,617
-517,569
| -50% | -$12.3M | ﹤0.01% | 1946 |
|
|
2019
Q4 | $24.7M | Buy |
1,034,186
+95,823
| +10% | +$1.95M | 0.01% | 1476 |
|
|
2019
Q3 | $16.6M | Buy |
938,363
+301,957
| +47% | +$5.83M | ﹤0.01% | 1649 |
|
|
2019
Q2 | $16.3M | Sell |
636,406
-95,813
| -13% | -$2.67M | ﹤0.01% | 1660 |
|
|
2019
Q1 | $21.3M | Sell |
732,219
-302,938
| -29% | -$7.85M | 0.01% | 1394 |
|
|
2018
Q4 | $13.6M | Buy |
1,035,157
+385,663
| +59% | +$6.15M | ﹤0.01% | 1804 |
|
|
2018
Q3 | $13.1M | Sell |
649,494
-55,789
| -8% | -$1.26M | ﹤0.01% | 2124 |
|
|
2018
Q2 | $16.7M | Buy |
705,283
+35,263
| +5% | +$908K | ﹤0.01% | 1814 |
|
|
2018
Q1 | $15.1M | Buy |
670,020
+318,503
| +91% | +$8.38M | ﹤0.01% | 1945 |
|
|
2017
Q4 | $11M | Buy |
351,517
+77,730
| +28% | +$2.3M | ﹤0.01% | 2314 |
|
|
2017
Q3 | $8.54M | Sell |
273,787
-135,954
| -33% | -$2.59M | ﹤0.01% | 2436 |
|
|
2017
Q2 | $7.03M | Sell |
409,741
-135,773
| -25% | -$2.32M | ﹤0.01% | 2506 |
|
|
2017
Q1 | $9.55M | Buy |
545,514
+14,412
| +3% | +$222K | ﹤0.01% | 2239 |
|
|
2016
Q4 | $7.03M | Buy |
531,102
+143,766
| +37% | +$1.96M | ﹤0.01% | 2636 |
|
|
2016
Q3 | $5.62M | Sell |
387,336
-21,445
| -5% | -$268K | ﹤0.01% | 2551 |
|
|
2016
Q2 | $4.03M | Sell |
408,781
-282,243
| -41% | -$3.29M | ﹤0.01% | 2816 |
|
|
2016
Q1 | $8.76M | Sell |
691,024
-56,561
| -8% | -$744K | ﹤0.01% | 1976 |
|
|
2015
Q4 | $13.6M | Sell |
747,585
-121,236
| -14% | -$2.14M | ﹤0.01% | 1726 |
|
|
2015
Q3 | $16.1M | Buy |
868,821
+96,761
| +13% | +$2.42M | 0.01% | 1564 |
|
|
2015
Q2 | $18.9M | Buy |
772,060
+283,758
| +58% | +$6.44M | 0.01% | 1544 |
|
|
2015
Q1 | $10.2M | Buy |
488,302
+63,671
| +15% | +$1.12M | ﹤0.01% | 2045 |
|
|
2014
Q4 | $6.57M | Buy |
424,631
+389,762
| +1,118% | +$5.53M | ﹤0.01% | 2461 |
|
|
2014
Q3 | $455K | Sell |
34,869
-3,592
| -9% | -$54.2K | ﹤0.01% | 4637 |
|
|
2014
Q2 | $768K | Sell |
38,461
-20,224
| -34% | -$299K | ﹤0.01% | 4265 |
|
|
2014
Q1 | $1.12M | Buy |
58,685
+17,141
| +41% | +$326K | ﹤0.01% | 3893 |
|
|
2013
Q4 | $706K | Buy |
41,544
+10,844
| +35% | +$166K | ﹤0.01% | 4215 |
|
|
2013
Q3 | $480K | Sell |
30,700
-64,441
| -68% | -$819K | ﹤0.01% | 4357 |
|
|
2013
Q2 | $1.14M | Buy |
+95,141
| New | +$972K | ﹤0.01% | 3620 |
|
Other funds holding INSM
BBA
DGM
OAG
Morgan Stanley's INSM Position: Q2 2026 in Review
Morgan Stanley reduced its Insmed (INSM) stake by 7.4% in Q2 2026, selling an estimated $11.9M and leaving 1,233,498 shares worth $132M. The position accounts for 0.01% of the portfolio, ranked #1337.
Morgan Stanley first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $284M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Morgan Stanley held 1,233,498 shares of Insmed worth $132M as of Q2 2026.
- Morgan Stanley sold 98,044 Insmed shares in Q2 2026, an estimated $11.9M.
- Insmed made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1337 holding.
- Morgan Stanley first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Insmed position peaked at $284M in Q4 2025.
- 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.